Junaidi, Khaled
Xeris Pharmaceuticals (United States)
2 papers on CoChatORCID 0000-0003-0581-5412
Most cited papers
- Verified
Comparison of a ready-to-use liquid glucagon injection administered by autoinjector to glucagon emergency kit for the symptomatic relief of severe hypoglycemia: Two randomized crossover non-inferiority studies
Christiansen, M. P., Cummins, M., Prestrelski, S., Close, N. C., Nguyen, A., & Junaidi, K. (2021) · BMJ Open Diabetes Research & Care
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 22
- Verified
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetes
Pieber, T. R., Aronson, R., Christiansen, M. P., Bode, B., Junaidi, K., & Conoscenti, V. (2022) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free